Medivir AB
Records under this name other than the patents Medivir AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 30 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,459,296 | Antibacterial Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,845,725 | Antibacterial Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 9,040,562 | Macrocyclic inhibitors of hepatitis C virus Term ended Ended no later than Jul 28, 2026 · From the USPTO record | Term ended | Ended no later than Jul 28, 2026 | From the USPTO record |
| US 8,022,230 | Dimeric Iap Inhibitors Formerly held Term ended Term ended Jul 10, 2026 · High confidence | Term ended | Term ended Jul 10, 2026 | High confidence |
| US 11,351,221 | SMAC mimetic Lapsed on the fee record Ended Jun 7, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2026 | From the USPTO record |
| US 8,735,395 | Protease inhibitors Lapsed on the fee record Ended May 27, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2026 | From the USPTO record |
| US 11,312,693 | Protease inhibitors Lapsed on the fee record Ended Apr 26, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2026 | From the USPTO record |
| US 8,822,525 | Dimeric Iap Inhibitors Formerly held Term ended Term ended Feb 27, 2026 · High confidence | Term ended | Term ended Feb 27, 2026 | High confidence |
| US 9,187,490 | Dimeric IAP Inhibitors Formerly held Term ended Term ended Feb 27, 2026 · Medium confidence | Term ended | Term ended Feb 27, 2026 | Medium confidence |
| US 9,920,093 | Dimeric IAP Inhibitors Formerly held Term ended Ended no later than Feb 27, 2026 · Medium confidence | Term ended | Ended no later than Feb 27, 2026 | Medium confidence |